How big is the Biosimilar Market | Market Share & Insights 2025

Q: How big is the biosimilar market?

The biosimilar market was estimated at USD 28 billion in 2024 and is projected to reach USD 91 billion by 2031.

Q: What is the expected growth rate of the biosimilar market by 2031?

The biosimilar market is projected to expand its landscape at a CAGR of 17.9% from 2025 to 2031.

Q: What are the major drivers of the biosimilar market?

Patent expirations of biologics, cost savings, and increased access to biological therapies.

Q: What challenges does the biosimilar market face?

Regulatory complexity, physician scepticism, brand loyalty to originators, and high development costs are the main challenges.

Q: How does 6W market outlook report help businesses in making decisions?

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.

Q: Do you also provide customisation in the market study?

Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

How big is the Biosimilar Market | Industry Trends & Forecast鈥�2025

Code: MTA5077

Publication Date: Jul 2025

What is the size of the Biosimilar Market?

According to 绿帽社 internal database and industry insights, the Global Biosimilar Market was demonstrated around USD 28 billion in 2024 and is projected to reach USD 91 billion by 2031, growing at a CAGR of 17.9% during the forecast period 2025鈥�2031.

Due to growth factor such as the patent expiration of blockbuster biologics and increased demand for cost-effective therapies in chronic disease treatment, the biosimilar market is predicted to grow in the forthcoming years.

Key Growth Factors of the Biosimilar Market

Expiration of patents for major biologic drugs.
Increasing prevalence of chronic conditions such as cancer and autoimmune diseases.
Growing acceptance of biosimilars by physicians and patients.
Government initiatives to reduce healthcare costs.
Expanding production capabilities and regulatory support across emerging markets.

Biosimilar Market Trends

There are numbers of notable trends such as the rising competition among biosimilar manufacturers following the patent cliff of biologics like Humira and Herceptin. The market has noticed proliferation in strategic partnerships between pharmaceutical giants and biosimilar-focused companies to accelerate product development. Other notable trend is the adoption of subcutaneous formulations and self-injection devices which are growing to enhance patient convenience. Furthermore, the market is witnessing a geographic expansion of approvals beyond the U.S. and Europe into Latin America and Asia-Pacific.

Emerging Developments in the Biosimilar Market

Biosimilar market has been emphasizing to focus on the advancement of analytical and manufacturing technologies which enables faster and more cost-efficient biosimilar production. Bio betters which have enhanced properties of biosimilar, are beginning to emerge as an innovation trend. Now, the companies are investing in AI and machine learning for biosimilar drug development optimization and pharmacovigilance. Further, interchangeable biosimilars are gaining regulatory traction in the U.S., potentially reshaping the prescription and substitution practices.